Ferulic acid/GRB2/NF-κB signaling pathway that alleviates ferroptosis-induced apoptosis of nucleus pulposus cells is a potential mechanism for intervertebral disc degeneration
Article History
-
Received: ,
Accepted: ,
Abstract
Abstract
Intervertebral disc degeneration (IDD) is one of the main causes of low back pain, and its pathogenesis involves the gradual loss of nucleus pulposus cells (NPCs). However, the molecular mechanisms linking these pathways are not yet fully understood.
This study aims to investigate the role of ferulic acid (FA) in IDD and its potential mechanisms of action, providing potential therapeutic targets for IDD.
Analysis of 10 common traditional Chinese medicine prescriptions for lumbar disc herniation revealed that ferulic acid (Ferulic acid, FA) is a major active pharmaceutical ingredient. CCK8 confirmed that FA promotes the proliferation of NP cells. Edu results showed that FA promotes NP cell proliferation, while ferroptosis inhibits NP proliferation. Moreover, FA can alleviate the inhibitory effect of ferroptosis on NP cell proliferation. Subsequently, animal experiments confirmed that FA alleviates IDD in rats, and safranin O-fast green staining results confirmed that FA has a role in alleviating IDD lesions. Analysis of the GSE15227 and GSE23130 datasets showed that GRB2 is a hub gene in the progression of IDD, and molecular docking results showed that FA can bind to GRB2. WB demonstrated that FA significantly increased the expression of IκBα in ferroptosis-induced NP cells, thereby promoting proliferation. Meanwhile, the addition of the NF-κB agonist (TNF-α) significantly reduced IκBα expression and significantly inhibited NP cell proliferation.
FA significantly inhibited ferroptosis markers and NPC proliferation in NPCs. GRB2 is one of the hub genes of IDD, and molecular docking results showed that FA has binding sites with GRB2. Meanwhile, FA upregulated IκBα, inhibiting the nuclear translocation of NF-κB and its downstream pro-inflammatory cytokines.
FA can significantly alleviate the progression of IDD. FA may inhibit NPC inflammation and lipid peroxidation through the GRB2/NF-κB pathway, The FA-GRB2/NF-κB axis is a potential therapeutic target for intervertebral disc degeneration.
Keywords
This article was originally published by Reed Elsevier India Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
1 Introduction
Low back pain (LBP) is one of the leading causes of disability worldwide and is closely related to intervertebral disc degeneration (IVDD). 1,2 IVDD is a pathological process characterized by the degradation of the extracellular matrix (ECM), inflammation, oxidative stress, and programmed cell death of nucleus pulposus cells (NPCs). 3 Among the various mechanisms driving IVDD, ferroptosis—a newly discovered form of iron-dependent regulated cell death, marked by lipid peroxidation and inactivation of glutathione peroxidase 4 (GPX4)—has emerged as a key factor in NPC loss and disc degeneration. Studies have shown that excessive iron accumulation in degenerated discs exacerbates the production of reactive oxygen species (ROS), 4,5 leading to mitochondrial dysfunction and irreversible NPC damage. 6–8 Meanwhile, apoptosis, another key factor in IVDD, further accelerates disc degeneration through caspase activation and regulation by Bcl-2 family proteins. Although progress has been made in understanding these pathways, current treatments mainly target symptoms rather than the underlying molecular mechanisms, highlighting the urgent need for new therapies.
Ferulic acid (FA) is a natural phenolic compound with strong antioxidant and anti-inflammatory properties, showing potential in alleviating oxidative stress-related diseases. 9 Recent evidence suggests that FA modulates signaling pathways involved in cell survival and death, including the nuclear factor κB (NF-κB) pathway, a major regulator of inflammation and apoptosis. 10 NF-κB activation promotes the transcription of pro-inflammatory cytokines (e.g., TNF-α, IL-6) and apoptotic factors, exacerbating NPC dysfunction in IVDD. Interestingly, growth factor receptor-bound protein 2 (GRB2) is an intracellular signaling adapter protein that interacts with NF-κB to regulate cellular responses to stress and inflammation. 11 However, the role of the GRB2/NF-κB axis in ferroptosis-related IVDD has not been explored.
Emerging studies suggest crosstalk between ferroptosis and apoptosis in degenerative diseases. For example, p53, a tumor suppressor gene, not only induces apoptosis but also sensitizes cells to ferroptosis by downregulating SLC7A11, a component of the cystine/glutamate antiporter system Xc−. In IVDD, iron overload and excessive ROS production create a vicious cycle that synergistically activates ferroptosis and apoptosis pathways, exacerbating NPC loss. 12–14 Therefore, targeting these intertwined pathways may provide dual therapeutic benefits. Preliminary data indicate that FA inhibits NF-κB activation and apoptosis in osteoarthritic chondrocytes, 15,16 but its effects on ferroptosis and the GRB2/NF-κB axis in NPCs are unclear.
This study hypothesizes that FA alleviates ferroptosis-induced NPC apoptosis by inhibiting GRB2/NF-κB signaling, thereby mitigating IVDD. We propose that FA reduces iron accumulation and lipid peroxidation by enhancing GPX4 activity and inhibiting ROS production, while blocking NF-κB-mediated inflammatory and apoptotic cascades. By elucidating the crosstalk between ferroptosis, apoptosis, and the GRB2/NF-κB pathway, this study aims to identify new mechanisms by which FA alleviates disc degeneration, providing a potential basis for targeted therapies for IVDD.
2 Materials
SD rats (200–250 g, Shanghai Experimental Animal Center); Human intervertebral disc cells (NP, NOSAI, CP-H097), Ferulic acid (537-98-4) (purity >98 %) purchased from Chengdu Pufei De Biotechnology Co., Ltd. (Chengdu, China). Dimethyl sulfoxide (DMSO) and collagenase II purchased from Sigma-Aldrich (St. Louis, MO, USA). Rabbit polyclonal GPX4 (23KD) Wuhan Sanying 30388-1-AP; Rabbit polyclonal SLC7A11 (55KD) Wuhan Sanying 26864-1-AP; Rabbit polyclonal IKBα (36KD) Wuhan Sanying 10268-1-AP; HRP-conjugated goat anti-mouse secondary antibody Wuhan Boster BA1051; HRP-conjugated goat anti-rabbit secondary antibody Wuhan Boster BA1054; ECL substrate liquid affinity KF8003.
3 Methods
3.1 Animal experiments and sample tissue processing
Sprague-Dawley rats (200–250 g) were purchased from the Shanghai Experimental Animal Center (12 rats were used, with 6 females and 6 males). The rats were acclimated for 3 days. They were randomly divided into three groups with four rats per group: 1) Normal control group; 2) IDD + saline; 3) IDD + ferulic acid. After one week of acclimatization, the annulus fibrosus puncture method was used to create the model. The rats were anesthetized, and the right abdomen and lumbar back were shaved, cleaned, and disinfected with iodine. The surgical area was draped. A longitudinal incision was made on the right posterior lateral side, and the skin and subcutaneous tissues were sequentially incised. The L5/6 intervertebral disc and endplates were exposed via an extraperitoneal approach. A 21G puncture needle was inserted through the anterolateral side of the annulus fibrosus in a direction parallel to the endplate, with a depth controlled at approximately 2.3 mm. The needle was left in place for 10 s before removal, and the incision was sutured layer by layer. The sham surgery group did not undergo puncture during the surgery and was directly sutured layer by layer after the operation. The IDD model was established 24 h later, and the rats were treated with the drug. After the treatment, the rats were euthanized, and the L5/6 intervertebral disc tissues were carefully dissected. Subsequently, the tissues were decalcified, dehydrated with gradient alcohol, cleared, infiltrated with wax, embedded, sectioned, and baked. The sections were dewaxed, stained with safranin O and fast green, cleared with xylene, air-dried, and mounted with neutral gum for data processing.
3.2 Cell viability analysis
The cytotoxicity of ferulic acid on NP cells was determined using the Cell Counting Kit-8 (CCK-8; Dojindo Co., Kumamoto). As described in previous studies, 18 NP cells were treated with ferulic acid for 24 h, washed once with phosphate-buffered saline (PBS), and then 100 μl of DMEM/F12 solution containing 10 μl of CCK-8 was added to each well of the plate, which was incubated at 37 °C for 2 h. The optical density (OD) was measured at 450 nm using a microplate reader. All experiments were repeated three times.
3.3 EDU
After EdU labeling of the cells was completed, the culture medium was removed, and 1 ml of 4 % paraformaldehyde was added to fix the cells at room temperature for 15 min. The fixative was removed, and the cells in each well were washed three times with 1 ml of washing solution. The washing solution was removed, and the cells in each well were incubated with 1 ml of PBS containing 0.3 % Triton X-100 at room temperature for 15 min. The permeabilization solution was removed, and the cells in each well were washed twice with 1 ml of washing solution. 0.5 ml of Click reaction solution was added to each well, and the culture plate was gently shaken to ensure that the reaction mixture could evenly cover the samples. The cells were incubated at room temperature in the dark for 30 min. The Click reaction solution was removed, and the cells were washed three times with washing solution. Preparation of 1X Hoechst 33342 solution: Hoechst 33342 (1000X) was diluted 1:1000 with PBS. After removing the washing solution, 1 ml of 1X Hoechst 33342 solution was added to each well, and the cells were incubated at room temperature in the dark for 10 min. The 1X Hoechst 33342 solution was removed, and the cells were washed three times with washing solution. The liquid on the coverslip was dried with absorbent paper, and the coverslip was mounted with mounting medium containing an anti-fluorescence quenching agent, and then images were collected under a fluorescence microscope.
3.4 Western blot
Total protein was extracted from NP cells using RIPA lysis buffer containing 1 mM PMSF (Phenylmethanesulfonyl fluoride). The concentration of the extracted protein was measured using the BCA protein detection kit (Beyotime). The protein concentration was determined. Subsequently, the proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene fluoride (PVDF) membranes (Bio-Rad, USA). After blocking non-specific proteins with 5 % skim milk, the PVDF membranes were incubated with specific primary antibodies against cleaved GPX4 (1:1000), SLC7A11 (1:1000), and IκBα (1:1000) overnight at 4 °C. The membranes were then washed and incubated with secondary antibodies corresponding to the primary antibodies at room temperature. As described in previous studies, 20 the bands were detected using chemiluminescent reagents (Invitrogen), and the intensity of the bands was quantified using Image Lab 3.0 software (Bio-Rad).
3.5 Paraffin section staining with safranin O and fast green
Tissue dehydration was performed using a biological tissue dehydrator (after decalcification): The tissue was dehydrated with gradient alcohol, followed by tissue clearing. The tissue block, after alcohol dehydration, must be cleared. The clearing agent (xylene) can mix with both anhydrous ethanol and paraffin, allowing paraffin to penetrate the tissue smoothly. Embedding: The wax-soaked tissue was embedded in an embedding machine. Melted wax was placed in the embedding frame, and before the wax solidified, the tissue was taken out from the dehydration box and placed into the embedding frame with the corresponding label attached. The embedding frame was cooled on a −20 °C cold plate. After the wax solidified, the wax block was taken out from the embedding frame and trimmed. Sectioning and baking: The embedded wax block was sectioned using a Leica histopathology microtome, with a thickness of approximately 4 μm. The sectioned tissue was placed in a water bath at 40 °C for spreading. A silane-coated slide was inserted into the water at an angle to retrieve the section, which was then attached to the appropriate position on the slide. The slide was baked in an oven at 60 °C for 3 h. The sections were dewaxed and then washed with distilled water for 5 min. Fast green staining: The sections were stained with bone tissue fast green staining solution for 1–5 min, washed with running tap water to remove excess dye until the cartilage appeared colorless, treated quickly with 1 % hydrochloric acid for 10–15 s, and slightly washed with water. Safranin O staining: The sections were stained with bone tissue safranin O staining solution for 5–10 s, then quickly dehydrated with anhydrous ethanol in four containers, each for 3–5 s. After the fourth dehydration, the sections were examined under a microscope until the cartilage appeared red and the background was colorless. The sections were cleared with xylene, air-dried, and mounted with neutral gum.
4 Statistical analysis
All experiments were performed at least three times. The statistical analysis of the experimental results was conducted using SPSS statistical software version 20.0. The data were analyzed using one-way analysis of variance (ANOVA), followed by Tukey's test or t-test (and non-parametric tests) for comparisons between the control and treatment groups. Non-parametric data (Pfirrmann grading) were analyzed using the Kruskal-Wallis H test. P < 0.05 was considered statistically significant.
5 Results
5.1 Ferulic acid is a major active component in traditional Chinese medicine prescriptions for the treatment of intervertebral disc degeneration
Table 1:Angelicae Sinensis Radix and Chuanxiong Rhizoma are key ingredients in all the prescriptions listed. From Table 1, we can see that Angelicae Sinensis Radix (Danggui) and Chuanxiong Rhizoma (Chuanxiong) are among the main ingredients in all the prescriptions. Previous studies have shown that ferulic acid is a major component of both Danggui and Chuanxiong.
| Solitary Angelica and Parasitic Decoction | Solitary Angelica Root, Saposhnikoviae Radix, Chuanxiong Rhizoma, Achyranthes Radix, Mulberry Parasitic Herb, Gentianae Macrophyllae Radix, Eucommiae Cortex, Angelicae Sinensis Radix, Poria Cocos, Ginseng Radix et Rhizoma, Rehmanniae Radix Preparata, Paeoniae Radix Alba, Asari Radix et Rhizoma, Glycyrrhizae Radix et Rhizoma, Cinnamomi Cortex |
| Pain-Relieving and Stasis-Eliminating Decoction | Gentianae Macrophyllae Radix, Persicae Semen, Carthami Flos, Angelicae Sinensis Radix, Chuanxiong Rhizoma, Myrrha, Trogopterori Feces, Notopterygii Rhizoma et Radix, Lumbricus, Cyperi Rhizoma, Achyranthes Radix, Glycyrrhizae Radix et Rhizoma |
| Liver-Tonifying and Lumbar-Strengthening Prescription | Angelicae Sinensis Radix, Chuanxiong Rhizoma, Paeoniae Radix Alba, Rehmanniae Radix Preparata, Jujubae Fructus, Eucommiae Cortex, Corydalis Rhizoma, Scorpio, Buthus Martensis, Glycyrrhizae Radix et Rhizoma |
| Kidney-Tonifying and Blood-Activating Prescription | Drynariae Rhizoma, Psoraleae Fructus, Cibotii Rhizoma, Rehmanniae Radix Preparata, Achyranthes Radix, Angelicae Sinensis Radix, Notopterygii Rhizoma et Radix, Solitary Angelica Root, Carthami Flos, Chaenomelis Fructus, Chuanxiong Rhizoma |
| Blood-Activating and Lumbar-Strengthening Decoction | Angelicae Sinensis Radix, Chuanxiong Rhizoma, Paeoniae Radix Rubra, Rehmanniae Radix Preparata, Millettiae Cortex, Corydalis Rhizoma, Dipsaci Radix, Scorpio, Buthus Martensis, Glycyrrhizae Radix et Rhizoma |
| Muscle-Stretching and Blood-Activating Decoction | Lycopodii Herba, Chaenomelis Fructus, Paeoniae Radix Alba, Glycyrrhizae Radix et Rhizoma, Angelicae Sinensis Radix, Cyathulae Radix, Gentianae Macrophyllae Radix, Mulberry Parasitic Herb, Cibotii Rhizoma, Dipsaci Radix, Frankincense, Myrrha |
| Kidney-Tonifying and Blood-Activating Prescription | Dipsaci Radix, Lycopodii Herba, Eupolyphagae Corpora, Angelicae Sinensis Radix, Chuanxiong Rhizoma, Lumbricus, Eucommiae Cortex, Carthami Flos, Myrrha, Dodder Seed |
| Blood-Activating and Kidney-Tonifying Prescription I | Rehmanniae Radix Preparata, Achyranthes Radix, Angelicae Sinensis Radix, Corni Fructus, Dipsaci Radix, Eucommiae Cortex, Paeoniae Radix Alba, Poria Cocos, Acanthopanacis Cortex |
| Qi-Tonifying and Blood-Activating Prescription | Astragali Radix, Angelicae Sinensis Radix, Chuanxiong Rhizoma, Lumbricus, Stephaniae Tetrandrae Radix, Chaenomelis Fructus, Brassicae Semen Album, Clematidis Radix et Rhizoma |
| Blood-Activating and Kidney-Tonifying Prescription II | Solitary Angelica Root, Eucommiae Cortex, Viscum Album, Rehmanniae Radix Preparata, Chuanxiong Rhizoma, Angelicae Sinensis Radix, Paeoniae Radix Rubra, Achyranthes Radix |
5.2 Ferulic acid promotes proliferation of NP cells
To confirm the effect of ferulic acid on NP cells, two experimental controls were set up: Group A, NP cells + saline; Group B, NP cells + ferulic acid (concentration gradient of 0 μm, 2 μm, 5 μm, 10 μm, 20 μm, 30 μm) of ferulic acid was applied to NP cells and cultured for 48h, followed by CCK8 detection of cell viability. The results are shown in Fig. 1A: NP cells were treated with ferulic acid (10 μmol/L), with a control group set up, Group A: NP cells + saline; Group B: NP cells + ferulic acid. EDU detection was used to assess the proliferation of NP cells, and the results showed that the proliferation rate of NP cells in Group B was significantly higher than that in the control group, as shown in Fig. 1B.

5.3 Ferulic acid alleviates intervertebral disc degeneration in rats
Twenty-four hours after the induction of intervertebral disc degeneration (IDD) in rats, the animals were divided into three groups: A. Normal control group; B. IDD + saline group; C. IDD + ferulic acid (Fad) group. The interventions included saline and ferulic acid at a concentration of 10 mmol/L. After the intervention, the rats were sacrificed, and X-ray images were taken. Subsequently, the L5/6 intervertebral disc tissues were carefully dissected, and sections were prepared and stained with safranin O and fast green. The degree of intervertebral disc degeneration in rats was evaluated according to the modified Thompson grading system. Group A: The intervertebral disc had a normal appearance, uniform signal, and clear boundaries with adjacent vertebrae, which was classified as grade 1. Group B: The intervertebral disc signal was significantly reduced, and the shape and structure were altered, with signs of collapse and fusion, which were classified as grades 3–4. Group C: The intervertebral disc signal was mildly decreased, but it still maintained a certain shape and structure, which was classified as grade 2, as shown in Fig. 2A. The staining results showed that the other two groups had more obvious cartilage destruction and more significant loss of proteoglycan compared with the IDD + Fad group. The above results demonstrate that ferulic acid has a protective effect on IDD, as shown in Fig. 2B.


5.4 Ferulic acid alleviates the inhibition of NP cell proliferation induced by ferroptosis inducers
Numerous previous studies have shown that ferroptosis plays an important role in the occurrence and progression of IDD. The use of the ferroptosis inducer Erastin to intervene in NP cells showed that the induction of ferroptosis significantly inhibited the proliferation of NP cells, as shown in Fig. 3.
5.5 Exploring the potential mechanisms of intervertebral disc degeneration
5.5.1 GRB2 is one of the hub genes in intervertebral disc degeneration
To further explore the potential mechanisms of IDD, we analyzed the GEO datasets GSE15227 and GSE23130, which included normal and intervertebral disc degeneration groups (discs at stages II and below were defined as the normal group: G1, and those at stage III and above were defined as the intervertebral disc degeneration group: G2). First, we performed data reproducibility analysis (as shown in Fig. 4A1, 4A2, 4A3, and Fig. 4B1, 4B2), followed by differential expression analysis. Genes with p < 0.05 were considered significantly differentially expressed and were analyzed further. We constructed a PPI network using STRING and analyzed it with cytoHubba to identify the top 10 hub genes, ultimately selecting GRB2 as the target gene, as shown in Fig. 4C.

5.5.2 GRB2 can dock with ferulic acid and is a potential target for its action
To further confirm the potential interaction between ferulic acid and GRB2, we performed molecular docking using Discovery Studio 2019, as shown in Fig. 5. The results indicate that GRB2 can successfully dock with ferulic acid, suggesting that GRB2 is a potential target for the action of ferulic acid.


5.5.3 Exploring the potential mechanisms
To further explore the mechanism by which ferulic acid alleviates the inhibitory effect of ferroptosis inducers on NP cell proliferation, we established five groups: A: NP + saline; B: NP + Erastin; C: NP + Ferulic acid (Fad); D: NP + Erastin + Fad; E: NP + Erastin + Fad + TNF-α (NF-κB activator). Previous results have shown that ferulic acid can significantly alleviate the inhibitory effect of ferroptosis on NP cell proliferation. In this experiment, based on the NP + Erastin + Ferulic acid group, we used an NF-κB activator. The results showed that the proliferation in group C was significantly lower than that in group B, and the alleviating effect of ferulic acid on the inhibitory effect of ferroptosis on NP cell proliferation disappeared. Meanwhile, the WB results showed that the expression of GPX4, SLC7A11, and IκBα in group B was significantly lower than that in group A. There was no significant difference in the expression of GPX4 and SLC7A11 between groups A and C, but the expression of IκBα in group C was significantly higher than that in group A. In group E, the expression of GPX4, SLC7A11, and IκBα was significantly higher than that in group B. These results indicate that ferroptosis significantly affects the NF-κB signaling pathway (IκBα) in NP cells. In normal NP cells, ferulic acid did not affect the ferroptosis process but did affect the NF-κB signaling pathway. However, in NP cells induced by ferroptosis inducers (undergoing ferroptosis or diseased NP cells), ferulic acid can affect the ferroptosis process: it increases the key ferroptosis proteins GPX4 and SLC7A11 while inhibiting the NF-κB signaling pathway (IκBα expression). The results of groups D and E showed that the expression of GPX4, SLC7A11, and IκBα in group D was significantly lower than that in group E. The NF-κB activator eliminated the protective effect of ferulic acid on NP cells, as shown in the figure below.
6 Discussion
Lumbar degeneration usually begins with the aging of nucleus pulposus cells or mechanical trauma. These factors lead to the sclerosis and loosening of the endplate, a process that is clinically associated with low back pain. 17–19 Currently, clinical treatments for lumbar degeneration include pharmacological and surgical interventions, but these methods cannot stop disease progression or restore disc function. 20 A large number of studies have focused on the regeneration of degenerated discs, including the use of growth factors and stem cell transplantation. 21,22 However, such research is still in its infancy. Therefore, understanding the key mechanisms of lumbar degeneration will help us discover therapeutic targets.
Numerous studies have shown that ferroptosis and the NF-κB signaling pathway play important roles in the progression and occurrence of IDD. 23,24 The mechanism of action of ferulic acid on IDD has not been reported so far. Ferulic acid is a phenolic compound widely found in plants and is an important active component of many traditional Chinese medicines. It plays an important role in oxidative stress, inflammation, vascular endothelial damage, fibrosis, apoptosis, and platelet aggregation. Many studies have shown that ferulic acid can inhibit NF-κB, the PI3K/AKT pathway, the production of ROS, and the activity of aldose reductase.10,25 Analysis of more than 10 traditional Chinese medicine prescriptions for the treatment of lumbar degeneration found that ferulic acid is the common active component of more than 10 classic prescriptions for the treatment of lumbar disc herniation. Moreover, both cell and animal experimental results have shown that ferulic acid has a protective effect on IDD. To explore the potential mechanism of action of ferulic acid on IDD, we conducted further investigations: First, bioinformatics analysis identified GRB2 as a hub gene in the progression of IDD. GRB2 is an adaptor protein that can bind to receptor tyrosine kinases such as epidermal growth factor receptor (EGFR) to activate signaling pathways such as PI3K/AKT and ERK/MAPK, thereby regulating cell proliferation, differentiation, and migration.26,27 In the progression of IDD, GRB2 may affect cell proliferation and invasion through specific signaling pathways, thereby influencing the degeneration process of the intervertebral disc. In other disease models, abnormal expression or activity changes of GRB2 can affect the apoptosis process of cells. Therefore, it is speculated that GRB2 may affect the survival of intervertebral disc cells and the integrity of intervertebral disc tissue by regulating cell apoptosis in IDD. Subsequently, we performed molecular docking of ferulic acid with GRB2, and the results showed that GRB2 is a potential target for the action of ferulic acid.
Our experimental data show that ferulic acid can promote the expression of IκBα. IκBα can anchor NF-κB in the cytoplasm, preventing it from entering the nucleus and activating the transcription of target genes, thereby inhibiting the NF-κB signaling pathway.28 However, when NP cells undergo ferroptosis or degenerative changes (induced by Erastin), ferulic acid can significantly alleviate ferroptosis (with significant increases in GPX4 and SLC7A11) while further promoting the expression of IκBα. This is consistent with the results of previous studies.10,25 Our data show that the NF-κB activator (TNF-α) can offset the protective effect of ferulic acid on NP cells. This further proves that ferulic acid protects NP cells through the ferroptosis and NF-κB signaling pathways, slowing down the apoptosis of NP cells.
This study has proven the protective effect of ferulic acid on the progression of IDD at both the cellular and animal experimental levels. The ferulic acid/GRB2/NF-κB signaling pathway that alleviates ferroptosis-induced apoptosis of nucleus pulposus cells is a potential mechanism for intervertebral disc degeneration.
CRediT authorship contribution statement
Minde Li: designed the experiments and analyzed, generated data, wrote the manuscript. Xinya Liu: raises animals for medical purposes and collects data, All authors contributed to the article and approved the submitted version.
Guardian/patient's consent
Not applicable.
Ethics declarations ethics approval and consent to participate
The study was conducted in accordance with the Declaration of Helsinki and approved by Institutional Ethics Committee of the WuhanMyhalicBioteehnology Co.,Ltd (HLK-20240426-001). All animal experimental protocol has been carried out in accordance with relevant guidelines and all methods are reported in accordance with ARRIVE guidelines (https://arriveguidelines.org) and approved by the Use Committee for Animal Care at the WuhanMyhalicBioteehnology Co.,Ltd. All methods were carried out in accordance with relevant guidelines and regulations. Informed consent was obtained from all individuals or individuals’ guardians. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
The animal study was reviewed and approved by the WuhanMyhalicBioteehnology Co.,Ltd.
Funding statement
Not applicable.
References
- Global,regional,and national incidence,prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories,1990-2017:a systematic analy⁃ sis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789-1858.
- [Google Scholar]
- Prospective clinical study on natural history of discogenic low back pain at 4 years of followup. Pain Physician. 2012;15(6):525-532.
- [Google Scholar]
- Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer. Proc Natl Acad Sci USA. 2020;117(51):32433-32442.
- [Google Scholar]
- A nuclear long non-coding RNA LINC00618 accelerates ferroptosis in a manner dependent upon apoptosis. Mol Ther. 2021;29(1):263-274.
- [Google Scholar]
- ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation. Cell Death Dis. 2019;10(11):822.
- [Google Scholar]
- ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy. Acta Biomater. 2022;140:492-505.
- [Google Scholar]
- FSP1 is a glutathione independent ferroptosis suppressor. Nature. 2019;575(7784):693-698.
- [Google Scholar]
- Ferulic acid as a therapeutic agent in depression: evidence from preclinical studies. CNS Neurosci Ther. 2023 Sep;29(9):2397-2412.
- [Google Scholar]
- Ferulic acid alleviates sciatica by inhibiting neuroinflammation and promoting nerve repair via the TLR4/NF-κB pathway. CNS Neurosci Ther. 2023 Apr;29(4):1000-1011.
- [Google Scholar]
- Osteopontin deficiency promotes cartilaginous endplate degeneration by enhancing the NF-κB signaling to recruit macrophages and activate the NLRP3 inflammasome. Bone Res. 2024 Sep 6;12(1):53.
- [Google Scholar]
- Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53. EMBO Rep. 2019;20(7)
- [Google Scholar]
- BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018;20(10):1181-1192.
- [Google Scholar]
- Ferulic acid suppresses interleukin-1β-induced degeneration of chondrocytes isolated from patients with osteoarthritis through the SIRT1/AMPK/PGC-1α signaling pathway. Immun Inflamm Dis. 2021 Sep;9(3):710-720.
- [Google Scholar]
- Ferulic acid attenuates osteoporosis induced by glucocorticoid through regulating the GSK-3β/Lrp-5/ERK signalling pathways. Phys Int. 2021 Sep 15;108(3):317-341.
- [Google Scholar]
- Wogonoside inhibits IL-1beta induced catabolism and hypertrophy in mouse chondrocyte and ameliorates murine osteoarthritis. Oncotarget. 2017;8(37):61440-61456.
- [Google Scholar]
- Accumulation and localization of macrophage phenotypes with human intevertebral disc degeneration. Spine J. 2018;18:343-356.
- [Google Scholar]
- HSP90 inhibitor 17-AAG attenuates nucleus pulposus inflammation and catabolism induced by M1-Polarized macropha-ges. Front Cell Dev Biol. 2021;9
- [Google Scholar]
- The emerging roles of nanocarrier drug delivery system in treatment of intervertebral disc degeneration-current knowledge, hot spots, challenges and future perspectives. Drug Des Dev Ther. 2024 Mar 29;18:1007-1022.
- [Google Scholar]
- Exosomes from umbilical cord mesenchymal stem cells ameliorate intervertebral disc degeneration via repairing mitochondrial dysfunction. J Orthop Translat. 2024 May 27;46:103-115.
- [Google Scholar]
- Ferrostatin-1 inhibits toll-like receptor 4/NF-κB signaling to alleviate intervertebral disc degeneration in rats. Am J Pathol. 2023 Apr;193(4):430-441.
- [Google Scholar]
- TNFα-reliant FSP1 up-regulation promotes intervertebral disc degeneration via caspase 3-dependent apoptosis. Genes Dis. 2024 Feb 28;12(1)
- [Google Scholar]
- Ferulic acid: a review of its pharmacology, pharmacokinetics and derivatives. Life Sci. 2021 Nov 1;284
- [Google Scholar]
- Casticin impairs cell migration and invasion of mouse melanoma B16F10 cells via PI3K/AKT and NF-κB signaling pathways. Environ Toxicol. 2017 Sep;32(9):2097-2112.
- [Google Scholar]
- The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus. Front Endocrinol. 2022 Sep 13;13
- [Google Scholar]

